We built clinicaltrial software in Africafor the world.
The only African clinical trial software dual-compliant with the US FDA and the European EMA. Founded in Pretoria in 2015. Deployed across 65+ countries on five continents.
Africa carries roughly a quarter of the global disease burden.
It hosts less than 3% of clinical trials.
Paper-based processes, fragmented data and expensive international software were the obstacles. In 2015, Adriaan Kruger and Abraham van Wyk founded nuvoteQ in Pretoria to remove them — purpose-built electronic research records for the African context, engineered to meet the world's strictest regulatory frameworks from day one.
A decade on, the platforms are deployed across five continents. The mission hasn't changed: world-class software, built in Africa, accessible everywhere.
“Our goal is to offer our customers world-class software built in Africa for Africa, at an affordable price.”
Cost-effective.
Affordable, enterprise-grade software that competes directly with global platforms on capability, not on price.
Flexible & adaptable.
A configurable front-end over a cohesive, interoperable back-end. Every deployment fits the customer's protocol via our no-code front-end interface.
Accessible to all.
Engineered for resource-constrained research environments and decentralised, multi-site African trials.
Configurable front-end.
Cohesive, interoperable back-end.
We specialise in Electronic Research Records (ERR) for clinical research — eliminating the paper, transcription and fragmentation that slow down trials. Every customer's protocol fits via a no-code front-end interface, not consulting hours.
100,000+
Users
65+
Countries
3M+
Visits
450+
Research Centres
Efficiency meets precision.
Five cross-functional specialists between Pretoria, Cape Town and the regional hubs — running technology, product, operations, customer success and digital from one accountable team.
Built in Pretoria.
Deployed everywhere.
Hazelwood Incub8tor, 47 Hazelwood Rd, Pretoria, 0081, South Africa — plus regional hubs across Africa, Asia and Latin America.
- HQ
Pretoria
South Africa
Cape Town
South Africa
Nairobi
Kenya
Bangalore
India
Belo Horizonte
Brazil
- Soon
Europe
Coming 2026
Three organisations.
One value chain.
Sponsors, CROs and research institutions engage with one integrated stack — contracted, supported and delivered as a single accountable partnership across the full trial lifecycle.
nuvoteQ
CoreClinical Trial Tech
Kronus (CTMS), Nukleus (EDC) and SafetyBase (PV) — the audit-ready platform backbone.
Scigenix.ai
AI · Data Science
Biostatistics, CDM, medical writing and AI tooling (LEXI, Checkm8, Project J) integrated directly with nuvoteQ data structures.
nuvoteQ Foundation
Non-profit · Public health
Gates- and EDCTP-funded programmes with SAHPRA and African NRAs — regulatory modernisation and capacity building.
Africa Business Heroes Top 20.
2025 cohort.
Jack Ma Foundation
CEO Adriaan Kruger selected as a top-3 finalist out of more than 32,000 continent-wide applicants — in recognition of nuvoteQ's contribution to clinical research infrastructure across Africa.
- Merck
- Pfizer
- Novartis
- GSK
- Gilead
- J&J
- Takeda
- Aspen
- Gates Foundation
- EDCTP
- Science for Africa
- CEPI
- KfW
- GIZ
- SAHPRA
- BOMRA
- NAFDAC
- Rwanda FDA
- AVAREF
- WHO-Afro
Disruptive Innovation. Simplified.